F Dx Advisors, Inc. Medpace Holdings, Inc. Transaction History

F Dx Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$284.87 - $413.31 $4,842 - $7,026	-17 Reduced 1.17%	1,436 $580,000
Q4 2023 Feb 12, 2024	SELL	$227.52 - $312.68 $38,678 - $53,155	-170 Reduced 10.47%	1,453 $445,000
Q3 2023 Nov 02, 2023	SELL	$233.98 - $281.67 $71,129 - $85,627	-304 Reduced 15.78%	1,623 $392,000
Q2 2023 Jul 17, 2023	BUY	$187.26 - $240.17 $360,850 - $462,807	1,927 New	1,927 $462,000
Q2 2022 Aug 03, 2022	BUY	$130.2 - $168.03 $266,259 - $343,621	2,045 New	2,045 $306,000
Q1 2022 May 03, 2022	SELL	$138.87 - $214.31 $355,090 - $547,990	-2,557 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$182.74 - $227.9 $194,800 - $242,941	1,066 Added 71.5%	2,557 $557,000
Q3 2021 Oct 08, 2021	BUY	$170.18 - $198.21 $40,162 - $46,777	236 Added 18.8%	1,491 $282,000
Q2 2021 Aug 05, 2021	SELL	$158.62 - $194.3 $3.25 Million - $3.98 Million	-20,468 Reduced 94.22%	1,255 $222,000
Q1 2020 May 13, 2020	BUY	$61.71 - $101.95 $1.34 Million - $2.21 Million	21,723 New	21,723 $96,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.